200 related articles for article (PubMed ID: 17010455)
1. Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B.
Wilder PT; Lin J; Bair CL; Charpentier TH; Yang D; Liriano M; Varney KM; Lee A; Oppenheim AB; Adhya S; Carrier F; Weber DJ
Biochim Biophys Acta; 2006 Nov; 1763(11):1284-97. PubMed ID: 17010455
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B.
Wafer LN; Streicher WW; McCallum SA; Makhatadze GI
Biochemistry; 2012 Sep; 51(36):7189-201. PubMed ID: 22913742
[TBL] [Abstract][Full Text] [Related]
3. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.
Inman KG; Yang R; Rustandi RR; Miller KE; Baldisseri DM; Weber DJ
J Mol Biol; 2002 Dec; 324(5):1003-14. PubMed ID: 12470955
[TBL] [Abstract][Full Text] [Related]
4. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
[TBL] [Abstract][Full Text] [Related]
5. Characterization of S-100b binding epitopes. Identification of a novel target, the actin capping protein, CapZ.
Ivanenkov VV; Jamieson GA; Gruenstein E; Dimlich RV
J Biol Chem; 1995 Jun; 270(24):14651-8. PubMed ID: 7540176
[TBL] [Abstract][Full Text] [Related]
6. S100B(betabeta) inhibits the protein kinase C-dependent phosphorylation of a peptide derived from p53 in a Ca2+-dependent manner.
Wilder PT; Rustandi RR; Drohat AC; Weber DJ
Protein Sci; 1998 Mar; 7(3):794-8. PubMed ID: 9541413
[TBL] [Abstract][Full Text] [Related]
7. The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53.
Rustandi RR; Drohat AC; Baldisseri DM; Wilder PT; Weber DJ
Biochemistry; 1998 Feb; 37(7):1951-60. PubMed ID: 9485322
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein.
Lin J; Blake M; Tang C; Zimmer D; Rustandi RR; Weber DJ; Carrier F
J Biol Chem; 2001 Sep; 276(37):35037-41. PubMed ID: 11454863
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
10. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
[TBL] [Abstract][Full Text] [Related]
11. Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction.
Fasan R; Dias RL; Moehle K; Zerbe O; Vrijbloed JW; Obrecht D; Robinson JA
Angew Chem Int Ed Engl; 2004 Apr; 43(16):2109-12. PubMed ID: 15083458
[No Abstract] [Full Text] [Related]
12. Molecular mechanism of the interaction between MDM2 and p53.
Schon O; Friedler A; Bycroft M; Freund SM; Fersht AR
J Mol Biol; 2002 Oct; 323(3):491-501. PubMed ID: 12381304
[TBL] [Abstract][Full Text] [Related]
13. Beta-peptides with improved affinity for hDM2 and hDMX.
Harker EA; Daniels DS; Guarracino DA; Schepartz A
Bioorg Med Chem; 2009 Mar; 17(5):2038-46. PubMed ID: 19211253
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein.
Baudier J; Delphin C; Grunwald D; Khochbin S; Lawrence JJ
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11627-31. PubMed ID: 1454855
[TBL] [Abstract][Full Text] [Related]
15. Computational screening and design of S100B ligand to block S100B-p53 interaction.
Whitlow JL; Varughese JF; Zhou Z; Bartolotti LJ; Li Y
J Mol Graph Model; 2009; 27(8):969-77. PubMed ID: 19324580
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase.
Bhattacharya S; Large E; Heizmann CW; Hemmings B; Chazin WJ
Biochemistry; 2003 Dec; 42(49):14416-26. PubMed ID: 14661952
[TBL] [Abstract][Full Text] [Related]
17. The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.
Charpentier TH; Thompson LE; Liriano MA; Varney KM; Wilder PT; Pozharski E; Toth EA; Weber DJ
J Mol Biol; 2010 Mar; 396(5):1227-43. PubMed ID: 20053360
[TBL] [Abstract][Full Text] [Related]
18. Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence.
Kane SA; Fleener CA; Zhang YS; Davis LJ; Musselman AL; Huang PS
Anal Biochem; 2000 Feb; 278(1):29-38. PubMed ID: 10640350
[TBL] [Abstract][Full Text] [Related]
19. Members of the S100 family bind p53 in two distinct ways.
Fernandez-Fernandez MR; Rutherford TJ; Fersht AR
Protein Sci; 2008 Oct; 17(10):1663-70. PubMed ID: 18694925
[TBL] [Abstract][Full Text] [Related]
20. Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.
Datta S; Bucks ME; Koley D; Lim PX; Savinov SN
Bioorg Med Chem; 2010 Aug; 18(16):6099-108. PubMed ID: 20638853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
